Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,449 | 168 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $372.10 | 17 | $0 (2024) |
| ABBVIE INC. | $327.08 | 16 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $308.52 | 16 | $0 (2024) |
| Novo Nordisk Inc | $296.41 | 15 | $0 (2024) |
| Bausch Health US, LLC | $285.25 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $280.13 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $279.74 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $276.32 | 15 | $0 (2021) |
| Lilly USA, LLC | $254.08 | 13 | $0 (2024) |
| Allergan, Inc. | $128.53 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $626.16 | 28 | GlaxoSmithKline, LLC. ($170.13) |
| 2023 | $787.30 | 38 | IDORSIA PHARMACEUTICALS US INC ($232.13) |
| 2022 | $312.44 | 11 | Bausch Health US, LLC ($179.55) |
| 2021 | $493.28 | 23 | AbbVie Inc. ($248.12) |
| 2020 | $317.53 | 17 | Allergan, Inc. ($128.53) |
| 2019 | $302.58 | 16 | PFIZER INC. ($57.55) |
| 2018 | $288.56 | 16 | Janssen Pharmaceuticals, Inc ($77.46) |
| 2017 | $321.06 | 19 | Merck Sharp & Dohme Corporation ($90.31) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: PAIN | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: PAIN | ||||||
| 09/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: PAIN | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: PAIN | ||||||
| 05/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Diabetes | ||||||
| 05/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.22 | General |
| 04/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: PAIN | ||||||
| 04/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Neurology | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.61 | General |
| 03/01/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Insomnia | ||||||
| 02/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,874 | 2,707 | $633,803 | $121,547 |
| 2022 | 9 | 1,671 | 2,466 | $584,381 | $110,689 |
| 2021 | 11 | 1,807 | 2,658 | $646,802 | $122,325 |
| 2020 | 16 | 1,647 | 2,278 | $534,681 | $94,794 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 383 | $210,650 | $43,231 | 20.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 208 | 208 | $133,536 | $30,855 | 23.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 380 | 609 | $124,845 | $14,919 | 11.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 109 | 110 | $18,296 | $8,295 | 45.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 365 | 589 | $85,405 | $7,381 | 8.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 46 | $34,270 | $7,301 | 21.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 383 | 632 | $13,152 | $5,309 | 40.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 112 | 113 | $12,204 | $3,965 | 32.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 14 | 17 | $1,445 | $291.21 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 382 | $210,100 | $43,984 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 155 | 155 | $99,510 | $23,805 | 23.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 331 | 510 | $104,550 | $12,833 | 12.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 56 | 68 | $50,660 | $11,472 | 22.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 353 | 563 | $81,635 | $6,987 | 8.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 81 | 82 | $11,890 | $5,745 | 48.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 86 | 87 | $9,396 | $3,011 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 359 | 607 | $12,140 | $1,798 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $4,500 | $1,053 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 221 | 373 | $205,242 | $42,962 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 207 | 207 | $132,894 | $32,304 | 24.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 325 | 483 | $99,015 | $13,295 | 13.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 53 | $39,485 | $8,759 | 22.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 350 | 591 | $85,695 | $7,690 | 9.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 89 | 89 | $12,905 | $5,912 | 45.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 51 | 64 | $29,585 | $4,739 | 16.0% |
About Dr. John Getsos, M.D
Dr. John Getsos, M.D is a Geriatric Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104049030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Getsos, M.D has received a total of $3,449 in payments from pharmaceutical and medical device companies, with $626.16 received in 2024. These payments were reported across 168 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,449).
As a Medicare-enrolled provider, Getsos has provided services to 6,999 Medicare beneficiaries, totaling 10,109 services with total Medicare billing of $449,355. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Internal Medicine
- Location New York, NY
- Active Since 04/10/2007
- Last Updated 08/14/2023
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1104049030
Products in Payments
- QUVIVIQ (Drug) $308.52
- ELIQUIS (Drug) $280.79
- UBRELVY (Drug) $273.19
- XARELTO (Drug) $248.59
- NURTEC ODT (Drug) $239.16
- Ozempic (Drug) $231.91
- TRELEGY ELLIPTA (Drug) $196.68
- APLENZIN (Drug) $175.00
- Repatha (Biological) $126.85
- JARDIANCE (Drug) $114.20
- MOUNJARO (Drug) $97.66
- WELLBUTRIN (Drug) $91.85
- MYRBETRIQ (Drug) $70.59
- JANUVIA (Drug) $70.27
- VRAYLAR (Drug) $62.81
- QULIPTA (Drug) $56.63
- Tresiba (Drug) $50.57
- FARXIGA (Drug) $48.97
- BEVESPI AEROSPHERE (Drug) $43.46
- TRULICITY (Drug) $42.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in New York
Dr. Howard Fillit, Md, MD
Geriatric Medicine — Payments: $64,263
Lisa Babitz, Md, MD
Geriatric Medicine — Payments: $7,071
Dr. Kenneth Mercer, Md Mph, MD MPH
Geriatric Medicine — Payments: $4,806
Laleh Moazen, M.d, M.D
Geriatric Medicine — Payments: $4,667
Laszlo Feher, Do, DO
Geriatric Medicine — Payments: $4,640
Dr. Eric Manheimer, Md, MD
Geriatric Medicine — Payments: $3,396